Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VILOXAZINE HYDROCHLORIDE, with a corresponding US DMF Number 40673.
Remarkably, this DMF maintains an Active status since its submission on January 24, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 10, 2025, and payment made on December 26, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II